BNP/CALL/MEDTRONIC/80/0.1/20.12.24 Share Price

Warrant

DE000PN3Y050

Market Closed - Deutsche Boerse AG 20:50:21 05/07/2024 BST
0.38 EUR +5.56% Intraday chart for BNP/CALL/MEDTRONIC/80/0.1/20.12.24
Current month-11.63%
1 month-41.54%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/07/24 0.38 +5.56%
04/07/24 0.36 +2.86%
03/07/24 0.35 -5.41%
02/07/24 0.37 +2.78%
01/07/24 0.36 -16.28%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 08:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN3Y05
ISINDE000PN3Y050
Date issued 25/05/2023
Strike 80 $
Maturity 20/12/2024 (166 Days)
Parity 10 : 1
Emission price 1.42
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.65
Lowest since issue 0.33
Delta0.49x
Omega 9.345
Premium8.21x
Gearing19.11x
Moneyness 0.9711
Difference Strike 2.39 $
Difference Strike %+2.99%
Spread 0.01
Spread %2.63%
Intrinsic value 0.000000

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.61 USD
Average target price
94.02 USD
Spread / Average Target
+21.15%
Consensus